HSPA5 and kidney cancer: The association of CALU with GPX4, HSPA5 and SLC7A11 in the pan-cancer data revealed a significant relationship between CALU and ferroptosis among various tumors, especially the breast, prostate and kidney cancers where ferroptosis was more commonly observed (Figure 8).